Generally, roughly half of women with MMR‐D nonmethylated endometrial cancer can be identified as having Lynch‐like syndrome which refers to individuals whose tumors show MMR deficiency but who are subsequently found not to carry an MMR gene mutation after germline DNA testing and who also show no evidence of MLH1 methylation.27 The gene discussed is MLH1; the disease is mismatch repair cancer syndrome 1.